The response rate proved equally impressive: 91.7% of participants at the 12mg dose achieved at least 10% weight loss, and the majority achieved 15% or greater
When in fact, if we looked at that, that study a little differently, hey, maybe the medication we're using isn't working [00:50:00] and that's why people aren't getting well
Preclinical studies demonstrated that GLP-1 receptor agonists increased bone formation and reduced bone resorption in metabolic bone disease models, including diabetic osteoporosis, postmenopausal osteoporosis, and glucocorticoid-induced osteoporosis
Efficacy and Safety of Semaglutide 7.2mg in ObesitySTEP UP Trial
Patients should report any side effects to their healthcare provider, who can advise on management strategies and adjust treatment if necessary
PMID: 40813933 SSRN2025 Jan 14